Drug Enforcement Administration December 2021 – Federal Register Recent Federal Regulation Documents

Gulf Med Pharmacy; Decision and Order
Document Number: 2021-27718
Type: Notice
Date: 2021-12-22
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Organix Inc.
Document Number: 2021-27635
Type: Notice
Date: 2021-12-21
Agency: Drug Enforcement Administration, Department of Justice
Organix Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Washington Bryan, M.D.; Decision and Order
Document Number: 2021-27431
Type: Notice
Date: 2021-12-20
Agency: Drug Enforcement Administration, Department of Justice
Peter S. Klainer, M.D.; Decision and Order
Document Number: 2021-27430
Type: Notice
Date: 2021-12-20
Agency: Drug Enforcement Administration, Department of Justice
Cypress Creek Pharmacy, LLC; Order
Document Number: 2021-27486
Type: Notice
Date: 2021-12-20
Agency: Drug Enforcement Administration, Department of Justice
Timothy C. Sapp, M.D.; Decision and Order
Document Number: 2021-27485
Type: Notice
Date: 2021-12-20
Agency: Drug Enforcement Administration, Department of Justice
Medical Pharmacy Decision and Order
Document Number: 2021-27416
Type: Notice
Date: 2021-12-20
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: SpecGX, LLC
Document Number: 2021-26907
Type: Notice
Date: 2021-12-13
Agency: Drug Enforcement Administration, Department of Justice
SpecGX, LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco, Inc.
Document Number: 2021-26906
Type: Notice
Date: 2021-12-13
Agency: Drug Enforcement Administration, Department of Justice
Noramco, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2021-26678
Type: Notice
Date: 2021-12-09
Agency: Drug Enforcement Administration, Department of Justice
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2021-26677
Type: Notice
Date: 2021-12-09
Agency: Drug Enforcement Administration, Department of Justice
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Noramco Coventry LLC
Document Number: 2021-26676
Type: Notice
Date: 2021-12-09
Agency: Drug Enforcement Administration, Department of Justice
Noramco Coventry LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Tamika Mayo, M.D.; Decision and Order
Document Number: 2021-26533
Type: Notice
Date: 2021-12-08
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I
Document Number: 2021-26293
Type: Proposed Rule
Date: 2021-12-07
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing 2- (ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, methoxetamine.
Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I
Document Number: 2021-26263
Type: Proposed Rule
Date: 2021-12-07
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule seven synthetic benzimidazole-opioid substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these seven specified controlled substances.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2021-26364
Type: Notice
Date: 2021-12-06
Agency: Drug Enforcement Administration, Department of Justice
Fisher Clinical Services, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Document Number: 2021-26363
Type: Notice
Date: 2021-12-06
Agency: Drug Enforcement Administration, Department of Justice
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Johnson Matthey Inc.
Document Number: 2021-26361
Type: Notice
Date: 2021-12-06
Agency: Drug Enforcement Administration, Department of Justice
Johnson Matthey Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022
Document Number: 2021-26227
Type: Notice
Date: 2021-12-02
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the initial 2022 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.